Atlas Trials

A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT02707640 · COMPLETED

Trial details

NCT number
NCT02707640
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis
Start date
2013-08-01
Primary completion
2015-02-01
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.